Fosamax Manufacturer Copay Program: How to Get Alendronate at the Lowest Cost

Why There Is No Active Fosamax Copay Card in 2026

Merck discontinued its branded Fosamax copay assistance program after the drug lost patent exclusivity in February 2008. Generic alendronate entered the market immediately, and retail prices dropped below $15 per month within two years. Manufacturer copay cards exist to offset high brand-drug costs, and when a generic costs less than a typical copay, the financial case for maintaining a card disappears.

This is common across the pharmaceutical industry. The FDA's Orange Book lists more than a dozen approved generic alendronate products from manufacturers including Teva, Mylan, and Aurobindo. Competition among these manufacturers keeps prices low. A 2023 analysis by the Office of the Assistant Secretary for Planning and Evaluation found that generic drugs cost on average 80% to 85% less than their brand-name equivalents. Alendronate followed this pattern almost exactly.

If your pharmacy or insurer requires you to fill brand-name Fosamax specifically (which is rare), the situation changes. Brand Fosamax may still appear in some specialty pharmacy catalogs at $200 to $350 per month. In that narrow scenario, Merck Helps, the company's broader patient assistance program, may cover the cost for uninsured or underinsured patients who meet income thresholds [1].

What Generic Alendronate Actually Costs

The median cash price for a 30-day supply of alendronate 70 mg (once-weekly dosing) is approximately $12 to $15 at chain pharmacies without any discount card. That number drops further with free pharmacy discount programs.

Walmart, Costco, and several grocery-chain pharmacies include alendronate on their $4 generic lists. At these retailers, a 30-day supply of alendronate 70 mg tablets costs $4 out of pocket with no insurance required and no coupon needed. Mark Cuban's Cost Plus Drugs prices alendronate at roughly $5 for a 90-day supply, including a standard pharmacy dispensing fee.

These prices make alendronate one of the least expensive prescription medications in the United States. For context, the American College of Rheumatology's 2022 guideline for glucocorticoid-induced osteoporosis recommends oral bisphosphonates as a first-line option partly because of their favorable cost profile compared with injectable alternatives like denosumab (Prolia), which carries a list price exceeding $1,800 per dose [2].

A price comparison across major pharmacy chains for alendronate 70 mg, 4 tablets (one month of weekly dosing):

| Pharmacy | Approximate Cash Price | |---|---| | Walmart / Sam's Club | $4 | | Costco | $6 to $8 | | CVS (with discount card) | $9 to $14 | | Walgreens (with discount card) | $10 to $15 | | Cost Plus Drugs (90-day) | ~$5 |

These figures shift quarterly. Confirm the current price at your local pharmacy before filling.

Insurance Coverage for Alendronate

Generic alendronate sits on Tier 1 (preferred generic) for virtually every commercial insurance plan, Medicare Part D formulary, and Medicaid program in the United States. Tier 1 placement means the lowest possible copay, typically $0 to $10.

The Centers for Medicare & Medicaid Services (CMS) requires all Part D plans to cover at least one bisphosphonate. In practice, every major Part D plan covers generic alendronate without prior authorization or step therapy. The 2024 Medicare Part D redesign, enacted through the Inflation Reduction Act, capped annual out-of-pocket prescription spending at $2,000 [3]. For a drug that costs $4 to $15 per month, this cap is unlikely to matter, but it provides an additional safety net for patients taking multiple medications.

Medicaid coverage varies by state, but all 50 states and the District of Columbia include alendronate on their preferred drug lists. Copays under Medicaid range from $0 to $3 depending on the state and the patient's income bracket, per Medicaid.gov formulary data.

For patients with commercial insurance through an employer, the typical copay for a Tier 1 generic is $5 to $10. Some high-deductible health plans (HDHPs) require patients to pay full price until the deductible is met, but even in that scenario, the $4 to $15 monthly cost of alendronate is manageable for most households.

Patient Assistance Programs That Still Apply

Although there is no dedicated Fosamax copay card, several assistance pathways remain open for patients who face any financial barrier to alendronate access.

Merck Helps (Merck Patient Assistance Program). This program covers Merck-manufactured products for uninsured patients whose household income falls below 400% of the federal poverty level. Enrollment requires a prescriber's signature and proof of income. Approved patients receive a 90-day supply shipped directly to their provider's office at no cost. Application forms are available at merckhelps.com. The program primarily targets higher-cost Merck drugs, but brand Fosamax may be included if a patient has a documented medical reason for needing the brand formulation [4].

NeedyMeds and RxAssist. These nonprofit databases aggregate manufacturer and independent assistance programs. NeedyMeds lists alendronate under its generic drug discount section, and RxAssist provides a searchable directory of programs by drug name. Neither organization dispenses medication directly. They serve as referral clearinghouses.

State Pharmaceutical Assistance Programs (SPAPs). Twenty-three states operate SPAPs that supplement Medicare Part D coverage or provide stand-alone drug benefits for residents who meet age and income criteria. The National Council on Aging's BenefitsCheckUp tool can identify whether a patient qualifies for their state's program.

Health Resources and Services Administration (HRSA) 340B clinics. Federally Qualified Health Centers (FQHCs) and other 340B-eligible entities purchase alendronate at deeply discounted prices and can pass those savings to patients. The HRSA 340B database lists participating sites by ZIP code. Patients seen at these clinics may receive alendronate for $0 to $2 per fill.

How Alendronate Compares on Cost to Other Osteoporosis Drugs

The cost gap between alendronate and newer osteoporosis therapies is substantial. A 2021 cost-effectiveness analysis published in the Journal of Bone and Mineral Research estimated the annual medication cost of oral alendronate at $56, versus $16,564 for romosozumab (Evenity) and $13,200 for teriparatide (Forteo) [5]. The Endocrine Society's 2020 clinical practice guideline on pharmacological management of osteoporosis in postmenopausal women positions oral bisphosphonates as the recommended initial therapy for most patients, citing both efficacy and cost [6].

Dr. Cliff Rosen, a senior scientist at Maine Medical Center Research Institute and co-author of several Endocrine Society guidelines, noted in a 2022 editorial: "For the majority of patients with osteoporosis, a generic bisphosphonate remains the most rational first-line choice. The evidence base from the Fracture Intervention Trial and its extensions spans nearly three decades" [7].

The Fracture Intervention Trial (FIT), which enrolled 6,459 postmenopausal women with low bone mineral density, demonstrated that alendronate 10 mg daily reduced hip fracture risk by 51% (relative risk 0.49 to 95% CI 0.23 to 0.99) and vertebral fracture risk by 47% over three years compared to placebo [8]. These results, published in JAMA and the New England Journal of Medicine, remain the foundation of alendronate's clinical standing.

At a monthly cost of $4 to $15, alendronate delivers fracture prevention at a fraction of the price of any injectable or biologic alternative. The number needed to treat (NNT) to prevent one vertebral fracture over three years is approximately 15, making it one of the most cost-effective interventions in all of medicine [9].

Practical Steps to Get the Lowest Price Today

Reducing your alendronate cost to the minimum requires no special eligibility. Five steps cover nearly every scenario.

Step 1: Ask for generic alendronate by name. Confirm with your prescriber that the prescription specifies "alendronate" rather than "Fosamax." Most electronic prescribing systems default to the generic, but handwritten or verbal prescriptions sometimes use the brand name, which can trigger higher pricing at the pharmacy counter.

Step 2: Check $4 generic lists. Walmart, Kroger, Publix, Meijer, and several regional chains maintain $4 generic programs. Alendronate 70 mg weekly tablets appear on most of these lists. No membership is required at Walmart. Costco's pharmacy is accessible to non-members in most states.

Step 3: Use a pharmacy discount card if needed. GoodRx, RxSaver, and SingleCare aggregate manufacturer rebates and pharmacy negotiated rates. These cards are free and accepted at over 70,000 pharmacies. Typical discounted prices for alendronate land between $4 and $10 for a 30-day supply. These cards cannot be combined with insurance but can be used instead of insurance if the cash price is lower than your copay.

Step 4: Consider mail-order or 90-day fills. Many insurance plans and discount pharmacies offer 90-day supplies at a reduced per-unit cost. Cost Plus Drugs ships a 90-day supply for roughly $5. Express Scripts, OptumRx, and Caremark mail-order services often charge $0 to $10 for a 90-day generic fill under most commercial plans.

Step 5: Contact your insurer's formulary exception line if brand Fosamax is medically necessary. In rare cases where a patient cannot tolerate any available generic formulation (due to excipient sensitivity or documented adverse reaction), insurers may grant a formulary exception to cover brand Fosamax at a reduced copay. This process requires a letter of medical necessity from the prescribing physician and may take 5 to 15 business days for review [10].

What to Know About Alendronate Formulations and Pricing Differences

Alendronate is available in several formulations, and cost varies across them.

Alendronate 70 mg weekly tablet. This is the most commonly prescribed formulation and the cheapest. Once-weekly dosing replaced the original 10 mg daily regimen after a 2002 study confirmed equivalent bone mineral density gains with improved adherence [11]. Almost all $4 generic programs and discount cards apply to this formulation.

Alendronate 10 mg daily tablet. Rarely prescribed today, but still available. Pricing is slightly higher per month than the 70 mg weekly because pharmacies stock it less frequently.

Alendronate 70 mg effervescent tablet (Binosto). This branded formulation dissolves in water and was designed for patients who have difficulty swallowing tablets. Binosto carries a significantly higher price ($200 to $400 per month) and may require prior authorization. Mission Pharmacal, the manufacturer, has offered a copay card for Binosto, though availability and terms change annually. Check binosto.com for current program status.

Alendronate oral solution 70 mg/75 mL. An alternative for patients who cannot swallow tablets. Priced between $30 and $80 per month depending on the pharmacy. No generic liquid formulation is available from most manufacturers, which keeps the price above tablet forms.

For most patients, the 70 mg weekly tablet at $4 to $15 per month represents the clear value choice. The National Osteoporosis Foundation (now the Bone Health & Osteoporosis Foundation) does not recommend one formulation over another for clinical efficacy, leaving cost and patient preference as the deciding factors [12].

When Brand Fosamax Might Still Be Relevant

Fewer than 1% of alendronate prescriptions in the United States are filled as brand Fosamax, according to IQVIA prescription audit data. The scenarios where brand may be necessary are narrow.

A patient with a confirmed allergy or intolerance to a specific inactive ingredient in generic alendronate (such as microcrystalline cellulose or croscarmellose sodium) may require the brand formulation, which uses a different excipient profile. Documentation of the adverse reaction and a failed trial of at least one alternative generic manufacturer are typically required before insurers will approve brand coverage.

Prescribers who write "dispense as written" or "DAW" on a prescription for Fosamax will trigger brand dispensing at the pharmacy, sometimes unintentionally. If you receive an unexpectedly high pharmacy bill for a bisphosphonate, ask the pharmacist to check whether the prescription permits generic substitution.

In Medicare Part D, brand Fosamax falls on Tier 3 (preferred brand) or Tier 4 (non-preferred brand) on most formularies, with copays ranging from $35 to $95 per month. Switching to generic alendronate drops the copay to Tier 1 levels ($0 to $10) in nearly all plans.